sFGL2 has also been shown to promote tumor progression through regulation of cholesterol metabolism in myeloid‐derived suppressor cells (MDSCs), with the key mechanism being suppression of CD8+ T‐cell proliferation [28]. The gene discussed is CD8A; the disease is neoplasm.